Investor AB’s AstraZeneca AZN Stock Holding History

Investor AB’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.78B	Hold	51,587,810	–	–	67.92%	1
2026 Q1	$10.2B	Buy	+51,587,810	New	+$9.95B	67.27%	1

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $148B AUM

Investor AB's AZN Position: Q2 2026 in Review

Investor AB held its AstraZeneca (AZN) position steady in Q2 2026 at 51,587,810 shares worth $9.78B. The position accounts for 67.92% of the portfolio, ranked #1.

Investor AB first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $10.2B in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Investor AB held 51,587,810 shares of AstraZeneca worth $9.78B as of Q2 2026.
Investor AB left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 67.92% of Investor AB's portfolio in Q2 2026, its #1 holding.
Investor AB first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
Investor AB's AstraZeneca position peaked at $10.2B in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Investor AB's 13F filing for Q2 2026, filed 14 Aug 2026.